Taiwan FDA registration c9efae52dd03894e63c4beebafee4265
"Simogine" Odosibe Cytosis II Fractional System
TW: “詩莫吉內” 奧多席貝血球細胞分離系統二代
Taiwan·Risk Class 2·THERMOGENESIS CORP.·Registered Jun 08, 2023 – Jun 08, 2028ActiveRegistration details
- Analysis ID
- c9efae52dd03894e63c4beebafee4265
- Customs Code
- DHA05603618704
Company information
- Manufacturer
- THERMOGENESIS CORP.
- Manufacturer Country
- United States
- Authorized Representative
- QUALTECH CONSULTING CORPORATION
Product details
- Intended Use
- This product is a cord blood processing system for laboratory use in conjunction with a specific and compatible single-use isolation kit provided by the original manufacturer. This product provides fast, automated, and reproducible separation of cord blood in a closed and sterile environment.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9900 Cord blood processing systems and storage containers
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Jun 08, 2023
- Expiry Date
- Jun 08, 2028
About this record
Access comprehensive regulatory information for "Simogine" Odosibe Cytosis II Fractional System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c9efae52dd03894e63c4beebafee4265 and manufactured by THERMOGENESIS CORP.. The authorized representative in Taiwan is QUALTECH CONSULTING CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices